Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia

Exclusion Criteria

• •History of allergic reactions to any of the active ingredients or to any of the ingredients of teh formulation;
• •Participants with a history of alcohol, substance, or illicit drug abuse disorder in the last 2 years;
• •Participants with conditions that may affect hair growth or with underlying conditions that cause hair loss, such as a diagnosis of alopecia areata, fibrosing or cicatricial alopecia, or telogen effluvium, the latter being present at the time of screening;
• •Participants with concomitant inflammation or other dermatological conditions of the scalp, such as moderate or severe psoriasis or seborrheic dermatitis, and/or active infection and/or keloid formation in the area of alopecia;